🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Me, between virtual clinic appointments

Spend Feb 13 with us when we discuss recent and ongoing #DM trials with Tina Vilsbøll, Dr. Darren K. McGuire, Dr. Subodh Verma, @PSJhund & Mark Petrie Dr. Marc Pfeffer is our Keynote speaker. Register free at global-trials-summit.hubilo.com #GTS2021

#Empa indicated in HFrEF via EU Medicines Agency ⚠️Jardiance is indicated in adults for the treatment of symptomatic chronic heart failure with reduced ejection fraction 📂 ema.europa.eu/en/medicines/h… Soc Esp Cardiología @ICyFA-SEMI

🌵 JUST OUT IN JACC Journals 🌵 Screening for cardiac amyloidosis (CA) 5-15 yrs after surgery for bilat. carpal tunnel syndrome finds approx. 5% with early-stage transthyretin CA. The clinical yield was ⏫ in non-obese👨🏼‍🦱>69 years. A study by Dr. Oscar Westin et al. 🫀 #RigsHeart

In this European Society of Cardiology Journals #QCCO sdy Pauline et al found decreasing ⬇️ risk of recurrent #myocardial_infarction, first-time admission 🏥 for #heartfailure and all-cause mortality 💀 in patients with a first-time myocardial infarction 🔗academic.oup.com/ehjqcco/advanc…

Early revascularization and GDMT as excellent secondary prevention strategies after #AMI – data over the last two decades in academic.oup.com/ehjqcco/advanc… #EHJQCCO #CVD #ACS Prof Chris P Gale Diogo Santos Ferreira

The Global Trials Summit is approaching! Take a look at the agenda👇👇 Felipe Albuquerque Fernando Fernando Cesena Pablo Corral MD Nicolas Renna, MD PhD ISHF FESC Fernando Botto, MD, MSc Augusto LC Ximena Reyes CarlosAguilarSalinas Carlos G Santos-Gallego, MD Claudio Tinoco Mesquita [email protected] Luis Beck da Silva MD ScD FESC 🇧🇷 Fer Nuñez

Please join us THIS Friday and Saturday for Global Trials Summit 2022. All of the major trials in heart failure, kidney disease, obesity, lipids, coronary heart disease and stroke. Register at gloaltrialssummit.com

Empagliflozin increases erythropoiesis 🩸 and augments early iron utilization in pts w HFrEF ❤️ These mechanisms may contribute to the cardioprotective properties of empagliflozin 💊 Paper by Camilla Fuchs Andersen et al in European Society of Cardiology Journals #heartfailure Article onlinelibrary.wiley.com/doi/10.1002/ej…

Effects of empagliflozin on erythropoiesis in heart failure - Now online as Open Access doi.org/10.1002/ejhf.2… Camilla Fuchs Andersen in European Society of Cardiology Journals #heartfailure